Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor Therapy - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Theranostics Year : 2016

Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor Therapy

Abstract

Fast clearance, metabolism and systemic toxicity are major limits for the clinical use of anti-cancer drugs. Histone deacetylase inhibitors (HDACi) present these defects despite displaying promising anti-tumor properties on tumor cells in vitro and in in vivo model of cancers. Specific delivery of anti-cancer drugs into the tumor should improve their clinical benefit by limiting systemic toxicity and by increasing the anti-tumor effect. In this work, we describe a simple and flexible polymeric nanoparticle platform highly targeting the tumor in vivo and triggering impressive tumor weight reduction when functionalized with HDACi. Our nanoparticles were produced by Ring Opening Metathesis Polymerization of azido-polyethylene oxide-norbornene macromonomers and functionalized using click chemistry. Using an orthotopic model of peritoneal invasive cancer, a highly selective accumulation of the particles in the tumor was obtained. A combination of epigenetic drugs involving a pH-responsive histone deacetylase inhibitor (HDACi) polymer conjugated to these particles gave 80% reduction of tumor weight without toxicity whereas the free HDACi has no effect. Our work demonstrates that the use of a nanovector with theranostic properties leads to an optimized delivery of potent HDACi in tumor and then, to an improvement of their anti-tumor properties in vivo.

Domains

Cancer
Fichier principal
Vignette du fichier
2016 El Bahhaj et al, Theranostics.pdf (1.39 Mo) Télécharger le fichier
Origin Files produced by the author(s)
Loading...

Dates and versions

inserm-01299450 , version 1 (07-04-2016)

Identifiers

Cite

Fatima El Bahhaj, Iza Denis, Pichavant Loic, Régis Delatouche, Floraine Collette, et al.. Histone Deacetylase Inhibitors Delivery using Nanoparticles with Intrinsic Passive Tumor Targeting Properties for Tumor Therapy. Theranostics, 2016, 6 (6), pp.795-807. ⟨10.7150/thno.13725⟩. ⟨inserm-01299450⟩
227 View
170 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More